Update in oncologySCHUCHTER, Lynn M; HALLER, Daniel G.Annals of internal medicine. 2000, Vol 133, Num 8, pp 615-621, issn 0003-4819Article

Psychosocial factors related to the correspondence of recipient and provider perceptions of social support among patients diagnosed with or at risk for malignant melanomaLICHTENTHAL, Wendy G; CRUESS, Dean G; MING, Michael E et al.Journal of health psychology. 2003, Vol 8, Num 6, pp 705-719, issn 1359-1053, 15 p.Article

Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice GuidelineWONG, Sandra L; BALCH, Charles M; DIRK NOYES, R et al.Journal of clinical oncology. 2012, Vol 30, Num 23, pp 2912-2918, issn 0732-183X, 7 p.Article

Physician and Stakeholder Perceptions of Conflict of Interest Policies in OncologyLOCKHART, A. Craig; BROSE, Marcia S; KIM, Edward S et al.Journal of clinical oncology. 2013, Vol 31, Num 13, pp 1677-1682, issn 0732-183X, 6 p.Article

American Society of Clinical Oncology 2008 Clinical Practice Guideline Update : Use of Chemotherapy and Radiation Therapy ProtectantsHENSLEY, Martee L; HAGERTY, Karen L; TATE THIGPEN, J et al.Journal of clinical oncology. 2009, Vol 27, Num 1, pp 127-145, issn 0732-183X, 19 p.Article

Multiple primary melanoma revisitedBLACKWOOD, M. Anne; HOLMES, Robin; SYNNESTVEDT, Marie et al.Cancer. 2002, Vol 94, Num 8, pp 2248-2255, issn 0008-543XArticle

P gene as an inherited biomarker of human eye colorREBBECK, Timothy R; KANETSKY, Peter A; WALKER, Amy H et al.Cancer epidemiology, biomarkers & prevention. 2002, Vol 11, Num 8, pp 782-784, issn 1055-9965Article

Drug Targeting of Oncogenic Pathways in MelanomaFECHER, Leslie A; AMARAVADI, Ravi K; SCHUCHTER, Lynn M et al.Hematology/oncology clinics of North America. 2009, Vol 23, Num 3, issn 0889-8588, x, 599-618 [20 p.]Article

Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening : A report from the american society of clinical oncologyOZOIS, Robert F; HERBST, Roy S; MARKMAN, Maurie et al.Journal of clinical oncology. 2007, Vol 25, Num 1, pp 146-162, issn 0732-183X, 17 p.Article

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: Clinical practice guidelines of the American Society of Clinical OncologySCHUCHTER, Lynn M; HENSLEY, Martee L; MEROPOL, Neal J et al.Journal of clinical oncology. 2002, Vol 20, Num 12, pp 2895-2903, issn 0732-183XArticle

Correlation of Somatic Mutations and Clinical Outcome in Melanoma Patients Treated with Carboplatin, Paclitaxel, and SorafenibWILSON, Melissa A; FENGMIN ZHAO; NATHANSON, Katherine L et al.Clinical cancer research (Print). 2014, Vol 20, Num 12, pp 3328-3337, issn 1078-0432, 10 p.Article

Melanoma Genetic Testing, Counseling, and Adherence to Skin Cancer Prevention and Detection BehaviorsGLANZ, Karen; VOLPICELLI, Kathryn; KANETSKY, Peter A et al.Cancer epidemiology, biomarkers & prevention. 2013, Vol 22, Num 4, pp 607-614, issn 1055-9965, 8 p.Article

Diverse cutaneous side effects associated with BRAF inhibitor therapy: A clinicopathologic studyCHU, Emily Y; WANAT, Karolyn A; ROSENBACH, Misha et al.Journal of the American Academy of Dermatology. 2012, Vol 67, Num 6, pp 1265-1272, issn 0190-9622, 8 p.Article

Clinical Cancer Advances 2007 : Major Research Advances in Cancer Treatment, Prevention, and Screening-A Report From the American Society of Clinical OncologyGRALOW, Julie; OZOLS, Robert F; KRAMER, Barnett S et al.Journal of clinical oncology. 2008, Vol 26, Num 2, pp 313-325, issn 0732-183X, 13 p.Article

A Phase I Trial of the Oral, Multikinase Inhibitor Sorafenib in Combination with Carboplatin and PaclitaxelFLAHERTY, Keith T; SCHILLER, Joan; JACOBETZ, Michael A et al.Clinical cancer research (Print). 2008, Vol 14, Num 15, pp 4836-4842, issn 1078-0432, 7 p.Article

Phase III Trial of Carboplatin and Paclitaxel With or Without Sorafenib in Metastatic MelanomaFLAHERTY, Keith T; LEE, Sandra J; FENGMIN ZHAO et al.Journal of clinical oncology. 2013, Vol 31, Num 3, pp 373-379, issn 0732-183X, 7 p.Article

Collapse of the CD27+ B-Cell Compartment Associated with Systemic Plasmacytosis in Patients with Advanced Melanoma and Other CancersCARPENTER, Erica L; MICK, Rosemarie; FECHER, Leslie A et al.Clinical cancer research (Print). 2009, Vol 15, Num 13, pp 4277-4287, issn 1078-0432, 11 p.Article

Phase II Trial of Temozolomide and Sorafenib in Advanced Melanoma Patients with or without Brain MetastasesAMARAVADI, Ravi K; SCHUCHTER, Lynn M; ATKINS, Michael B et al.Clinical cancer research (Print). 2009, Vol 15, Num 24, pp 7711-7718, issn 1078-0432, 8 p.Article

Telomerase-Specific T-Cell Immunity in Breast Cancer : Effect of Vaccination on Tumor ImmunosurveillanceDOMCHEK, Susan M; RECIO, Adri; VANCE, Barbara A et al.Cancer research (Baltimore). 2007, Vol 67, Num 21, pp 10546-10555, issn 0008-5472, 10 p.Article

Clinical cancer advances 2005: Major research advances in cancer treatment, prevention, and screening : A report from the american society of clinical oncologyHERBST, Roy S; BAJORIN, Dean F; LEVIN, Bernard et al.Journal of clinical oncology. 2006, Vol 24, Num 1, pp 190-205, issn 0732-183X, 16 p.Article